National Health Investors Management

Management criteria checks 4/4

National Health Investors' CEO is D. Mendelsohn, appointed in Aug 2015, has a tenure of 8.75 years. total yearly compensation is $2.08M, comprised of 24% salary and 76% bonuses, including company stock and options. directly owns 0.12% of the company’s shares, worth €3.21M. The average tenure of the management team and the board of directors is 6.7 years and 7.5 years respectively.

Key information

D. Mendelsohn

Chief executive officer

US$2.1m

Total compensation

CEO salary percentage	24.0%
CEO tenure	8.8yrs
CEO ownership	0.1%
Management average tenure	6.7yrs
Board average tenure	7.5yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has D. Mendelsohn's remuneration changed compared to National Health Investors's earnings?
Date	Total Compensation	Salary	Company Earnings
Dec 31 2023	US$2m	US$500k	US$136m
Sep 30 2023	n/a	n/a	US$105m
Jun 30 2023	n/a	n/a	US$110m
Mar 31 2023	n/a	n/a	US$92m
Dec 31 2022	US$3m	US$418k	US$66m
Sep 30 2022	n/a	n/a	US$71m
Jun 30 2022	n/a	n/a	US$68m
Mar 31 2022	n/a	n/a	US$85m
Dec 31 2021	US$3m	US$398k	US$112m
Sep 30 2021	n/a	n/a	US$142m
Jun 30 2021	n/a	n/a	US$154m
Mar 31 2021	n/a	n/a	US$159m
Dec 31 2020	US$2m	US$386k	US$185m
Sep 30 2020	n/a	n/a	US$190m
Jun 30 2020	n/a	n/a	US$190m
Mar 31 2020	n/a	n/a	US$186m
Dec 31 2019	US$2m	US$375k	US$160m
Sep 30 2019	n/a	n/a	US$155m
Jun 30 2019	n/a	n/a	US$154m
Mar 31 2019	n/a	n/a	US$152m
Dec 31 2018	US$2m	US$350k	US$154m
Sep 30 2018	n/a	n/a	US$155m
Jun 30 2018	n/a	n/a	US$153m
Mar 31 2018	n/a	n/a	US$154m
Dec 31 2017	US$2m	US$340k	US$159m

Compensation vs Market: D.'s total compensation ($USD2.08M) is about average for companies of similar size in the German market ($USD2.55M).

Compensation vs Earnings: D.'s compensation has been consistent with company performance over the past year.

CEO

D. Mendelsohn (61 yo)

8.8yrs

Tenure

US$2,084,567

Compensation

Mr. D. Eric Mendelsohn has been a Director at National Health Investors, Inc since February 17, 2021. Mr. Mendelsohn serves as the Chief Executive Officer and President at National Health Investors Inc. si...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
D. Mendelsohn	President	8.8yrs	US$2.08m	0.12% $ 3.2m
John Spaid	Executive VP of Finance	8.2yrs	US$1.30m	0.042% $ 1.1m
Kevin Pascoe	Executive VP & Chief Investment Officer	7.3yrs	US$1.19m	0.092% $ 2.4m
David Travis	Senior VP & Chief Accounting Officer	4yrs	US$1.02m	0.016% $ 413.7k
Kristin Gaines	Senior VP & Chief Transaction Officer	1.3yrs	US$1.05m	0.12% $ 3.1m
Dana Hambly	Director of Investor Relations	4.8yrs	no data	no data
Kimberly Ouimet	Director of Corporate Compliance & Human Resources	9.3yrs	no data	no data
Michelle Kelly	Senior Vice President of Investments	6.7yrs	no data	no data
Susan Sidwell	Corporate Secretary	no data	no data	no data
Colleen Schaller	Real Estate Transaction Manager	4.8yrs	no data	no data

6.7yrs

Average Tenure

51yo

Average Age

Experienced Management: WX6's management team is seasoned and experienced (6.7 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
D. Mendelsohn	President	3.3yrs	US$2.08m	0.12% $ 3.2m
W. Adams	Independent Chairman of the Board	33.3yrs	US$175.86k	1.97% $ 50.5m
Robert Adams	Independent Director	4yrs	US$175.86k	1.27% $ 32.5m
Charlotte Swafford	Independent Director	4yrs	US$175.86k	0.25% $ 6.5m
Robert McCabe	Independent Director	23.3yrs	US$190.86k	0.049% $ 1.2m
Robert Webb	Independent Director	33.3yrs	US$180.86k	0.24% $ 6.2m
Tracy M. Colden	Independent Director	1.9yrs	US$175.86k	0% $ 0
James Jobe	Independent Director	11.1yrs	US$180.86k	0.036% $ 914.9k

7.5yrs

Average Tenure

73.5yo

Average Age

Experienced Board: WX6's board of directors are considered experienced (7.5 years average tenure).

National Health Investors Management

Management criteria checks 4/4

Key information

Recent management updates

National Health Investors, Inc., Annual General Meeting, May 22, 2024

Insufficient new directors

Independent Director recently bought €541k worth of stock

Independent Director recently bought €53k worth of stock

Independent Director recently bought €97k worth of stock

Independent Director recently bought €138k worth of stock

Recent updates

Land & Buildings Issues Letter to Shareholders of National Health Investors Announcing its Intention to Vote Against Two Directors at 2024 Annual Meeting

National Health Investors, Inc. to Report Q1, 2024 Results on May 06, 2024

National Health Investors, Inc., Annual General Meeting, May 22, 2024

New major risk - Revenue and earnings growth

Upcoming dividend of US$0.90 per share

Insufficient new directors

Independent Director recently bought €541k worth of stock

Fourth quarter dividend of US$0.90 announced

National Health Investors, Inc. Provides Earnings Guidance for the Year 2024

Full year 2023 earnings released: EPS: US$3.13 (vs US$1.48 in FY 2022)

National Health Investors, Inc. Announces First Quarter Dividend, Payable on May 3, 2024

National Health Investors, Inc. to Report Q4, 2023 Results on Feb 20, 2024

Upcoming dividend of US$0.90 per share at 6.3% yield

National Health Investors, Inc. Provides Earnings Guidance for the Year 2023

National Health Investors, Inc. Announces Its Fourth Quarter Dividend, Payable on January 26, 2024

Third quarter 2023 earnings released: EPS: US$0.68 (vs US$0.78 in 3Q 2022)

National Health Investors, Inc. to Report Q3, 2023 Results on Nov 07, 2023

Upcoming dividend of US$0.90 per share at 7.1% yield

New minor risk - Earnings quality

Second quarter 2023 earnings released: EPS: US$0.92 (vs US$0.49 in 2Q 2022)

National Health Investors, Inc. Announces Third Quarter 2023 Dividend, Payable on November 3, 2023

National Health Investors, Inc. to Report Q2, 2023 Results on Aug 08, 2023

Upcoming dividend of US$0.90 per share at 6.8% yield

First quarter 2023 earnings released: EPS: US$0.80 (vs US$0.18 in 1Q 2022)

National Health Investors, Inc. Announces Second Quarter 2023 Dividend, Payable on August 4, 2023

Full year 2022 earnings released: EPS: US$1.48 (vs US$2.45 in FY 2021)

National Health Investors, Inc. to Report Q4, 2022 Results on Feb 21, 2023

Upcoming dividend of US$0.90 per share

Independent Director recently bought €53k worth of stock

National Health Investors, Inc. (NYSE:NHI) acquired Bickford of Virginia Beach from Bickford Senior Living, L.L.C. for $14 million.

Third quarter 2022 earnings released: FFO per share: US$1.0 (vs US$1.17 in 3Q 2021)

National Health Investors, Inc. Announces Fourth Quarter 2022 Dividend, Payable on January 27, 2023

National Health Investors, Inc. to Report Q3, 2022 Results on Nov 08, 2022

Upcoming dividend of US$0.90 per share

Independent Director recently bought €97k worth of stock

Second quarter 2022 earnings released: EPS: US$0.49 (vs US$0.85 in 2Q 2021)

National Health Investors, Inc. to Report Q2, 2022 Results on Aug 08, 2022

Upcoming dividend of US$0.90 per share

National Health Investors, Inc. Announces Impairment Charges for the First Quarter Ended March 31, 2022

First quarter 2022 earnings released: FFO: US$71.6m per share (vs US$1.25 in 1Q 2021)

An unknown buyer acquired Two Assisted Living Facilities Located in Texas from National Health Investors, Inc. (NYSE:NHI) for $7.8 million.

National Health Investors, Inc. to Report Q1, 2022 Results on May 09, 2022

National Health Investors, Inc. (NYSE:NHI) announces an Equity Buyback for $240 million worth of its shares.

Discovery Senior Living and National Health Investors, Inc. (NYSE:NHI) acquired 9-Community Independent Living Portfolio from Holiday AL Management Sub LLC.

Upcoming dividend of US$0.90 per share

National Health Investors, Inc. Declares First Quarter Dividend, Payable on May 6

Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat

An unknown buyer acquired Medical Office Building Located in Texas fromNational Health Investors, Inc. (NYSE:NHI) for approximately $5.1 million.

National Health Investors, Inc. to Report Q4, 2021 Results on Feb 22, 2022

Upcoming dividend of US$0.90 per share

Independent Director recently bought €138k worth of stock

Third quarter 2021 earnings released: FFO US$1.17 per share (vs US$1.42 in 3Q 2020)

President recently bought €94k worth of stock

Upcoming dividend of US$0.90 per share

Independent Director recently bought €74k worth of stock

Second quarter 2021 earnings released: FFO US$1.18 per share (vs US$1.47 in 2Q 2020)

National Health Investors, Inc.(NYSE:NHI) dropped from Russell 2000 Growth-Defensive Index

Independent Director recently bought €65k worth of stock

Upcoming dividend of US$0.90 per share

National Health Investors, Inc. (NYSE:NHI) acquired 48-unit Assisted Living and Memory Care Community in Manchester, TN for $6.6 million.

First quarter 2021 earnings released: FFO US$1.25 per share (vs US$1.38 in 1Q 2020)

An unknown buyer acquired Bickford Portfolio from National Health Investors, Inc. (NYSE:NHI) for $52.9 million.

Upcoming Dividend of US$1.10 Per Share

New 90-day high: €59.00

Full year 2020 earnings released: EPS US$4.14 (vs US$3.70 in FY 2019)

Revenue misses expectations

National Health Investors, Inc. Appoints Eric Mendelsohn as Directors

National Health Investors, Inc. to Report Q4, 2020 Results on Feb 22, 2021

New 90-day high: €56.50